0000029915-95-000036.txt : 19950919 0000029915-95-000036.hdr.sgml : 19950919 ACCESSION NUMBER: 0000029915-95-000036 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19950918 SROS: NYSE SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DOW CHEMICAL CO /DE/ CENTRAL INDEX KEY: 0000029915 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 381285128 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-36877 FILM NUMBER: 95574447 BUSINESS ADDRESS: STREET 1: 2030 DOW CENTER CITY: MIDLAND STATE: MI ZIP: 48674-2030 BUSINESS PHONE: 5176361000 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: DOW CHEMICAL CO /DE/ CENTRAL INDEX KEY: 0000029915 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] IRS NUMBER: 381285128 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 2030 DOW CENTER CITY: MIDLAND STATE: MI ZIP: 48674-2030 BUSINESS PHONE: 5176361000 SC 13D/A 1 SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 Amendment No. 1 NEOPROBE CORPORATION (Name of Issuer) COMMON STOCK, par value $0.001 per share (Title of Class of Securities) 640-518-10-6 (CUSIP Number) John Scriven Vice President and General Counsel The Dow Chemical Company 2030 Dow Center Midland, Michigan 48674 (517) 636-5914 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) June 30, 1995 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this Schedule because of Rule 13d-1(b)(3) or (4), check the following box [ ]. Check the following box if a fee is being paid with this statement [ ]. CUSIP No. 640-518-10-6 1) Name of Reporting Persons and its The Dow Chemical Company I.R.S. Identification No. I.R.S. Identification No. 38-1285128 2) Check the Appropriate Box if a (a) [ ] Member of a Group (b) [ x ] 3) SEC Use Only 4) Source of Funds WC, OO 5) Check Box if Disclosure of Legal Proceedings is Required Pursuant [ ] to Items 2(d) or 2(e) 6) Citizenship or Place of Organization Delaware Number of 7) Sole Voting Power 723,115; 4.5% Shares Beneficially 8) Shared Voting Power 0 Owned by Each 9) Sole Dispositive Power 723,155; 4.5% Reporting Person With 10) Shared Dispositive Power 0 11) Aggregate Amount Beneficially 723,115; 4.5% owned by Each Reporting Person as of June 28, 1995 12) Check Box if the Aggregate Amount [ ] in Row (11) Excludes Certain Shares 13) Percent of Class Represented by 4.5% Amount in Row (11) as of June 28, 1995 14) Type of Reporting Person CO This Amendment No. 1 amends the Statement of Schedule 13D filed by The Dow Chemical Company ("Dow"), with the Securities and Exchange Commission dated December 2, 1992, (the "Schedule 13D"). Item 5. Interest in Securities of the Issuer Item 5 of the Schedule 13D is hereby amended and supplemented by adding the following: (a) Dow has neither acquired nor disposed of any securities of Neoprobe Corporation ("Neoprobe") since November 10, 1992. As of the date of Neoprobe's most recently available filing with the Securities and Exchange Commission, Dow owned 723,115 shares of Neoprobe Corporation Common Stock, par value $0.001 per share (the"Securities"). Due to additional sales of Securities by Neoprobe to third parties, Dow's percentage ownership of the Securities has decreased to 4.5 percent. (b) Not applicable. (c) Not applicable. (d) Not applicable. (e) As of June 30, 1995, Dow ceased to be the holder of more than 5% of the common stock of Neoprobe Corporation. SIGNATURE After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: September 18, 1995 THE DOW CHEMICAL COMPANY By: /s/ Name: Roger L. Kesseler Title: Vice President, Controller